Dr. Samuel L. Barker is Independent Director at Cadence Pharmaceuticals, Inc., Independent Director at Lexicon Pharmaceuticals, Inc., and Strategic Advisor at Symphony Capital LLC.
He is on the Board of Directors at Cadence Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., and The Cancer Institute of New Jersey.
Dr. Barker was previously employed as a Principal by Clearview Projects, Inc., President by United States Pharmaceutical Group LLC, and EVP-Worldwide Franchise Management & Strategy by Bristol-Myers Squibb Co.
He also served on the board at AtheroGenics, Inc.
He received his undergraduate degree from Henderson State University (Arkansas), a graduate degree from The University of Arkansas, and a doctorate degree from Purdue University.